PNFP Stock Cash Flow Statements

Pinnacle Financial Partners Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Pinnacle Financial Partners Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2016-06-30	2016-03-31	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31

operating activities:
net income	158,540,000	140,408,000	151,259,000	146,691,000	53,162,000	123,944,000	94,979,000	132,603,000	197,299,000	137,271,000	137,847,000	148,658,000	145,127,000	129,110,000	133,528,000	136,577,000	131,790,000	125,428,000	110,876,000	110,645,000	62,444,000	28,356,000	96,079,000	110,521,000	100,321,000	93,960,000	95,318,000	93,747,000	30,786,772	27,965,264	16,367,123	15,320,594	14,646,950	14,310,532	13,448,125	11,730,158	11,349,125	10,439,644	8,364,954	43,701,389,430	26,100,999	6,371,847	3,504,724	3,795,789	2,090,974	-26,364,030	-3,823,225	-2,467,254	-3,347,170	-31,775,751	2,090,208	8,052,853	8,795,142	7,961,133	6,064,790	6,241,840	5,771,810	5,425,864	5,601,841	5,645,893	5,346,770	4,322,474	2,611,896	2,238,103	2,078,243	1,959,169	1,779,753	1,688,880	1,390,533	1,168,475	1,071,022
adjustments to reconcile net income to net cash from operating activities:
net amortization/accretion of premium/discount on securities	10,482,000	11,234,000	12,072,000	11,308,000	13,618,000	14,030,000	14,157,000	14,722,000	14,803,000	15,110,000	15,044,000	16,151,000	18,595,000	16,048,000	17,651,000	16,002,000	13,218,000	12,195,000	11,280,000	10,679,000	9,293,000	6,799,000	5,929,000	5,336,000	4,720,000	4,309,000	4,775,000	4,410,000	1,637,684	1,303,239	957,133	993,819	1,070,557	1,385,116	988,811	1,594,654	1,817,474	1,907,758	1,971,889	7,696,648,030	1,801,032	1,571,409	2,102,529	2,221,567	1,349,932	1,043,691	1,051,879	1,103,295	1,047,479	1,884,574	699,726	200,516
depreciation, amortization and accretion	27,858,000	27,280,000	25,905,000	25,076,000	24,505,000	23,096,000	19,281,000	19,133,000	19,855,000	20,429,000	17,612,000	15,358,000	14,961,000	14,367,000	13,626,000	12,573,000	13,008,000	14,049,000	13,076,000	11,096,000	10,812,000	10,219,000			1,808,000	468,000	-2,645,000	-7,864,000
benefit from credit losses	24,245,000	16,960,000	29,652,000	26,281,000	30,159,000	34,497,000	16,314,000	26,826,000	31,689,000	18,767,000	24,805,000	27,493,000	12,907,000	2,720,000	2,675,000	3,382,000	2,834,000	7,235,000	7,180,000	16,333,000	68,332,000	99,889,000
gain on mortgage loans sold	-1,965,000	-2,507,000		-2,643,000	-3,270,000	-2,879,000		-2,012,000	-1,567,000	-2,053,000		-1,117,000	-2,150,000	-4,066,000		-7,814,000	-6,700,000	-13,666,000		-19,453,000	-19,619,000	-8,583,000		-7,402,000	-6,011,000	-4,878,000		-3,902,000	-4,221,301	-3,567,551	-952,222	-1,113,000	-1,326,469	-1,990,454	-1,813,488	-1,768,428	-1,978,935
investment losses on sales	0	12,512,000		0										61,000
gain on other equity investments	-2,991,000	159,000	-4,737,000	-6,227,000	-3,266,000	-2,882,000	780,000	-5,838,000	-1,314,000	-2,360,000	-1,501,000	-725,000	-6,669,000	-1,710,000	-4,109,000
stock-based compensation expense	11,018,000	10,561,000	9,529,000	10,444,000	10,621,000	10,340,000	12,306,000	10,121,000	9,253,000	10,199,000	8,670,000	10,674,000	10,760,000	9,448,000	7,118,000	6,766,000	5,669,000	5,399,000	4,645,000	4,443,000	4,148,000	5,501,000	6,135,000	5,018,000	5,160,000	4,913,000	4,382,000	4,503,000	2,616,159	2,628,788	1,201,111	1,054,901	1,031,422	1,032,840	962,969	595,695	896,463	1,433,772	1,488,522	5,014,388,832	1,362,801	1,267,013	1,275,354	933,382	998,940	862,622	1,186,069	879,454	664,450	832,037	875,062	640,901	690,657	533,930	481,941	574,921	601,446	456,170	467,282	473,589	468,760	345,931	186,681
deferred tax benefit																																	-119,341	766,455	-698,661				-1,831,027								-1,529,004												-1,310,271	-53,846	44,895	-797,893	-357,492		45,736
losses on dispositions of other real estate and other investments	54,000	9,000		32,000	7,000	56,000														1,567,000											13,112		1,011,778				2,090,543	2,938,974	4,283,855
gain on sale of fixed assets	-202,000	-210,000	-38,000	-1,837,000			-102,000	-87,000
income from equity method investment	-26,027,000	-20,405,000	-12,070,000	-16,379,000	-18,688,000	-16,035,000	-14,432,000	-24,967,000	-26,924,000	-19,079,000	-21,005,000	-41,341,000	-49,465,000	-33,655,000	-30,844,000	-30,409,000	-32,071,000	-28,950,000	-24,294,000	-26,445,000	-17,208,000	-15,592,000	-12,312,000	-32,248,000	-32,261,000	-13,290,000	-17,936,000	-14,236,000
dividends received from equity method investment	77,223,000	24,934,000	0	24,816,000	43,272,000	3,601,000	3,535,000	5,567,000	3,631,000	23,961,000	3,713,000	18,639,000	28,530,000	12,232,000	3,775,000	16,812,000	39,416,000	9,993,000	5,039,000	40,024,000	0	7,957,000	1,372,000	9,026,000	28,248,000	12,666,000	0	10,218,000
excess tax benefit from stock compensation	-128,000	-3,605,000	-160,000	-131,000	-101,000	-2,414,000	33,000	16,000	20,000	-277,000	-106,000	0	-282,000	-2,639,000	-274,000	-334,000	-302,000	-1,565,000	88,000	85,000	272,000	-862,000	-179,000	-131,000	68,000	-769,000	-13,000	-199,000	-2,263,058	-159,168	-1,099,570	-156,639	-92,595	-111,553	-28,628	-4,547	-20,281	-6,265	-4,978	-13,808,990	-2,893	0	-7,117	-6,418	0	-8,037	-2,321	-9,174	0	-3,769	-40,595	-69,700	-404,979	-350,136	-50,299	22,869	-34,038	-73,898	-20,742
gain on commercial loans sold	-139,000	-467,000		-286,000	-183,000	-186,000		-202,000	-153,000	-53,000		-595,000	-1,191,000	-488,000		-780,000	-1,172,000	-1,184,000		-635,000	-624,000	-597,000		-1,032,000	-1,198,000	-611,000
commercial loans held for sale originated	-42,612,000	-62,603,000	-111,808,000	-54,942,000	-57,777,000	-51,031,000	-53,379,000	-91,934,000	-117,268,000	-106,007,000	-86,479,000	-137,078,000	-163,344,000	-111,411,000	-131,092,000	-145,524,000	-172,877,000	-115,154,000	-135,582,000
commercial loans held for sale sold	44,614,000	70,656,000	101,474,000	62,656,000	47,982,000	54,429,000	64,847,000	94,338,000	117,794,000	104,066,000	80,800,000	148,162,000	174,017,000	94,201,000	163,535,000	123,027,000	160,746,000	134,997,000	117,437,000
consumer loans held for sale originated	-809,232,000	-678,002,000	-686,240,000	-702,430,000	-647,245,000	-466,061,000	-459,763,000	-530,895,000	-464,251,000	-299,238,000	-315,144,000	-418,818,000	-426,538,000	-417,668,000	-458,152,000	-462,110,000	-477,611,000	-640,024,000	-572,506,000
consumer loans held for sale sold	753,160,000	712,832,000	691,555,000	713,628,000	567,948,000	468,570,000	475,915,000	499,398,000	438,596,000	284,770,000	318,351,000	441,893,000	428,445,000	400,316,000	471,863,000	471,619,000	513,111,000	655,743,000	579,820,000
increase in other assets	24,959,000	-86,175,000		-55,767,000															31,381,000	-15,347,000	-59,480,000	-113,848,000	21,963,000	-28,957,000	-43,988,000	-6,517,000				-6,736,913									15,794,855	42,322,900,263							8,397,287				1,135,420				273,098	-19,275,105	465,474	-772,420	2,035,596	-2,522,186	3,703,468	-6,386,348	-898,056	63,124	-1,669,671	-809,044	-740,234	-636,266	-457,404	-316,391	12,835
increase in other liabilities	36,351,000	-211,952,000	161,480,000	-51,082,000	13,582,000	30,470,000	-53,061,000			109,102,000	-69,760,000				-1,595,000	24,546,000	35,636,000	-118,902,000	16,834,000	-19,257,000	50,911,000	32,834,000	-12,360,000	56,394,000	-24,490,000	59,720,000	45,991,000	8,766,000				258,813				2,885,569	5,139,448	476,020	-3,128,767	10,993,640,878	6,941,501	3,482,817	595,804	-5,811,208	4,417,919	4,936,348	11,187,099	-9,978,122			2,293,669	12,028,874								3,065,164	-2,235,074			974,091	778,528
net cash from operating activities	261,732,000	-21,691,000	499,945,000	121,386,000	85,692,000	197,283,000	107,141,000	121,948,000	-110,555,000	359,870,000	104,718,000	300,028,000	148,064,000	52,115,000	218,764,000	141,120,000	174,387,000	123,173,000	126,100,000	116,527,000	128,588,000	56,610,000	119,784,000	130,459,000	28,754,000	155,291,000	152,257,000	107,961,000	35,249,487	24,027,474	13,000,033	26,933,705	44,772,826	30,696,686	24,032,135	28,297,983	29,855,214	13,770,243	42,354,225	113,002,583,512	21,596,948	29,708,189	35,866,351	36,336,305	36,284,325	19,121,792	37,846,690	17,874,092	40,300,589	15,938,996	16,191,862	-7,479,421	20,399,543	12,252,887	8,459,865			11,729,256	954,460	9,586,534	8,213,496	3,411,937	-9,305,806	6,123,343	2,383,351	-691,188	356,050	7,012,583	470,073	2,517,357	-3,257,941
investing activities:
activities in securities available-for-sale:
purchases	-731,206,000	-582,508,000	-561,086,000	-445,296,000	-1,477,739,000	-165,236,000	-199,819,000	-654,788,000	-36,706,000	-223,495,000	-30,433,000	-71,611,000	-551,670,000	-45,579,000	-500,261,000	-531,606,000	-773,060,000	-302,867,000	-222,288,000	-379,803,000	-402,997,000	-407,122,000	-415,848,000	-368,269,000	-358,351,000	-312,605,000	-290,845,000	-355,205,000	-163,453,586	-102,041,878	-57,753,116	-51,597,633	-53,367,783	-63,869,360	-65,052,729	-179,221,806	-6,365,214	-19,290,123	-17,954,670	-267,889,578,640	-182,486,101	-20,751,669	-49,158,590	-125,934,028	-176,348,565	-85,187,869	-161,445,670	-106,321,276	-38,478,577	-308,342,655	-267,868,777	-298,727,921	-127,359,518			-41,989,382	-17,531,124	-16,102,191	-3,355,360	-24,187,076	-27,794,458	-4,862,494	-5,916,658	-45,718,156	-29,656,391	-30,701,011	-10,285,511	-27,457,954	-36,024,041	-17,733,854	-51,539,860
sales	0	188,486,000	76,139,000	0			9,429,000	129,668,000			0	26,635,000	0	2,866,000	35,217,000	0			0	45,576,000	69,851,000	30,204,000	111,620,000	149,395,000	350,123,000	126,579,000	147,148,000	8,248,000				22,024,516	201,044			153,165,651	2,788,182	18,272,536	14,359,785	166,257,319,442	107,302,512	31,838,056	19,277,990	0	-954,388	116,605,097	30,431,826	0	0	145,674,452	201,221,131													0	0	0	6,791,867	0	6,584,452	0	21,876,953
maturities, prepayments and calls	235,095,000	66,753,000	84,421,000	132,160,000	68,813,000	39,236,000	30,880,000	30,642,000	48,513,000	29,216,000	80,415,000	96,166,000	147,437,000	93,330,000	160,507,000	175,752,000	153,954,000	126,841,000	112,647,000	170,198,000	98,328,000	88,164,000	118,950,000	104,006,000	76,531,000	72,813,000	79,893,000	93,810,000	75,513,435	28,996,005	23,192,675	31,779,843	33,610,222	34,380,752	43,551,916	48,363,826	55,937,870	49,845,665	56,585,619	233,442,372,761	61,431,893	57,678,057	60,713,289	59,849,458	117,040,765	65,617,785	79,906,149	89,204,457	45,557,070	104,674,657	45,514,061	94,438,594	17,006,290			21,324,868	9,714,081	10,400,822	10,078,338	9,248,260	9,305,527	9,535,684	7,479,033	10,292,494	9,034,451	7,563,044	6,045,226	9,538,921	6,613,743	10,007,097	9,012,617
activities in securities held-to-maturity:
net decrease (increase) in securities purchased under agreements to resell	-12,727,000	-14,117,000							2,637,000	3,404,000	15,723,000
increase in loans	-992,555,000	-679,602,000	-1,217,317,000	-570,653,000	-652,516,000	-505,746,000	-750,069,000	-810,646,000	-985,597,000	-1,266,114,000	-1,343,876,000	-1,391,334,000	-1,836,407,000	-1,062,733,000	-364,695,000	-169,506,000	179,255,000	-672,239,000	44,278,000	32,518,000	-2,126,276,000	-611,836,000	-439,375,000	-378,222,000	-647,274,000	-462,940,000	-238,267,000	-365,941,000	-270,822,843	-289,043,266	-40,306,647	-178,804,382	-47,976,416	-157,959,478	-63,167,119	-189,955,260	-84,036,356	-111,575,901	-54,941,031									3,305,730	-83,280,881	-120,744,616	-128,853,928	-164,924,922	-174,894,983	-177,492,120	-119,667,223	-153,252,846	-68,353,306	-107,756,893	-56,801,579
proceeds from sale of loans	0	9,131,000	39,097,000	10,245,000			0	0
purchases of software, premises and equipment	-17,139,000	-21,345,000		-25,338,000	-26,888,000	-17,316,000		-15,320,000	-11,037,000	-35,513,000		-24,403,000	-12,993,000	-10,072,000		-6,165,000	-4,747,000	-5,704,000		-11,646,000	-12,329,000	-6,334,000		-5,504,000	-26,576,000	-2,110,000		-3,994,000	-3,850,557	-2,849,721	-604,626		-983,321	-1,946,216	-1,442,076		-912,101	-668,991	-1,271,826
proceeds from sales of software, premises and equipment	7,381,000	532,000		5,135,000	555,000	129,000		186,000	197,810,000	418,000		364,000	120,000	172,000		0								14,000	-1,000	53,000		292,000
proceeds from sale of other real estate	904,000	146,000	781,000	1,855,000	123,000	1,549,000	269,000	0	5,496,000	253,000	0	674,000	1,000	319,000	362,000	1,545,000	2,203,000	1,980,000	6,081,000	2,061,000	3,334,000	1,796,000	3,499,000	1,830,000	2,277,000	840,000	2,884,000	3,638,000
purchase of bank owned life insurance policies	-50,000,000	-100,000,000										-25,000,000	0	-75,000,000										0	-50,000,000	-60,000,000		-50,000,000
proceeds from bank owned life insurance settlements				0	2,538,000	1,622,000						0				2,000				2,890,000				91,000
proceeds from bank owned life insurance surrender			0	0	0	141,308,000
purchase of derivative instruments	-13,025,000	-21,661,000
proceeds from sale (purchase) of fhlb stock	3,935,000	6,389,000										3,464,000
purchase of intangible asset
increase in other investments	-29,331,000	-39,271,000	-19,367,000	-928,000	-43,907,000	-29,730,000	-43,247,000	-20,338,000	22,736,000	-52,148,000	-22,022,000	-6,276,000	-43,892,000	-18,777,000	-39,262,000	-14,932,000	-9,180,000	-20,456,000	-20,919,000	-23,522,000	-15,920,000	-10,893,000	-12,666,000	-11,908,000	-18,770,000	-12,582,000	-9,231,000	-13,660,000	-15,025,457	-1,918,978		-2,530,104	-285,541	-3,021,837	-303,750
net cash from investing activities	-1,525,140,000	-1,164,006,000	-1,533,726,000	-822,647,000	-780,379,000	-535,700,000	-1,264,820,000	-1,311,924,000	-462,534,000	-1,563,161,000	-1,560,172,000	-792,855,000	-2,494,118,000	-1,837,294,000	-1,384,964,000	-540,783,000	-382,299,000	-1,304,909,000	-154,619,000	-157,331,000	-2,378,114,000	-878,598,000	-710,120,000	-552,106,000	-706,898,000	-649,937,000	-307,208,000	-682,812,000	-354,000,292	-435,889,309	-74,613,930	-188,804,327	-68,552,234	-190,846,717	-116,489,626	-171,419,066	-12,755,384	-63,984,310	-2,228,692	-13,154,868,452	-61,867,967	58,084,011	9,364,408	-60,634,950	-18,581,992	174,804,910	8,849,563	-24,732,535	-81,591,084	-189,911,364	-144,579,098	-379,253,738	-291,075,611	-201,629,309	-100,313,327	-139,654,672	-78,241,355	-114,695,117	-53,090,402	-112,325,981	-67,325,517			-81,284,868	-68,788,528	-65,372,352	-42,941,174	-58,217,924	-104,794,952	-40,909,388	-47,601,366
financing activities:
net increase in deposits	519,788,000	1,636,475,000	1,888,111,000	1,184,516,000	368,362,000	862,224,000	244,009,000	573,155,000	1,544,117,000	1,217,323,000	1,271,196,000	1,094,758,000	299,502,000	995,940,000	1,934,740,000	1,152,223,000	-75,297,000	587,418,000	1,161,680,000	1,022,195,000	4,188,746,000	1,152,246,000	180,470,000	551,423,000	969,064,000	-368,466,000	441,841,000	550,461,000	212,803,444	109,015,688		199,929,740	236,964,979			295,900,845	9,466,789			-178,540,355,973	-48,861,155	29,649,789	-101,153,661	7,459,967	-27,720,492	17,102,779	12,846,742	3,789,797	58,578,547	10,610,155	217,854,751	238,264,945	143,183,580	185,906,220	42,735,290	141,488,981	29,506,854	97,587,174	78,001,234	38,297,983	25,352,756	144,107,143	21,987,263	21,522,999	98,708,438	70,898,521	48,293,758	28,867,512	74,538,445	29,720,285	47,031,755
net increase in securities sold under agreements to repurchase	-5,539,000	33,749,000	20,288,000	-10,929,000			13,490,000	32,225,000	13,997,000	-45,133,000	4,356,000	-9,031,000	-19,945,000	66,971,000	4,319,000	-29,421,000	5,543,000	43,954,000		-67,494,000	8,005,000	60,194,000									-2,372,676		-33,313,799	-11,753,781	14,432,033				-13,502,880				18,837,951		31,901,851	-40,998,405	-74,976,494		538,749	5,544,163	25,293,195		15,618,484	12,001,970	15,115,628		4,889,143				17,974,354	40,467,999	-1,922,321		9,974,818	11,288,787	14,460,324		-814,444	9,073,300	-350,928
federal home loan bank: advances			0	4,650,000	0	450,000,000	0	0	1,250,000,000	2,175,000,000	100,000,000	0
federal home loan bank: repayments/maturities	-116,277,000	-26,000	-250,025,000	-9,000	0	-450,000,000	-1,000	-75,000,000	-1,200,000,000	-475,000,000	-525,000,000				-1,000	0	0	-200,000,000
principal payments of finance lease obligation	-68,000	-101,000	-98,000	-97,000	-96,000	-93,000	-87,000	-76,000	-75,000	-73,000	-74,000	-70,000	-70,000	-67,000	-67,000	-66,000	-64,000	-64,000	-63,000	-60,000	-61,000	-59,000		-57,000	-56,000	-55,000
restricted shares withheld for taxes & related tax benefits	-480,000	-5,786,000
issuance of common stock pursuant to rsu and psu agreements, net of shares withheld for taxes & related tax benefits	-15,000	-13,174,000
common stock dividends paid	-18,938,000	-18,828,000	-17,255,000	-17,245,000	-17,245,000	-17,269,000	-17,186,000	-17,186,000	-17,192,000	-17,173,000	-17,079,000	-17,074,000	-17,065,000	-16,976,000	-13,871,000	-13,868,000	-13,863,000	-13,902,000	-12,284,000	-12,285,000	-12,378,000	-12,442,000	-12,413,000	-12,438,000	-12,432,000	-12,545,000		-10,979,000	-5,925,558	-5,791,835	-2,824,493
preferred stock dividends paid	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000	-3,798,000
net cash from financing activities	374,673,000	1,628,511,000	1,636,542,000	1,156,508,000	366,243,000	814,429,000	235,926,000	508,947,000	1,586,744,000	2,845,385,000	829,312,000	664,438,000	658,186,000	1,003,421,000	1,801,234,000	974,793,000	-88,121,000	407,695,000	946,643,000	390,668,000	3,918,619,000	1,319,649,000	196,740,000	714,363,000	820,234,000	258,451,000	325,563,000	479,008,000	407,954,224	473,488,175	23,612,567	159,667,900	-6,250,177	301,761,809	26,728,088	160,270,865	-79,778,767	128,964,563	-80,221,245	-116,262,805,262	4,554,756	-12,311,229	-93,046,265	-37,689,238	-5,832,759	-50,502,434	-118,018,105	52,437,265	52,668,178	130,325,757	191,426,661	385,587,309	216,864,552	218,299,953	85,636,189	187,192,579	43,495,746	121,305,430	47,278,778	82,258,745	59,244,876	151,728,476	28,011,032	36,744,444	104,321,064	80,290,149	60,768,192	39,834,602	95,933,605	45,894,261	42,680,827
net increase in cash, cash equivalents, and restricted cash	-888,735,000	442,814,000	602,761,000	455,247,000	-328,444,000	476,012,000	-921,753,000	-681,029,000	1,013,655,000	1,642,094,000					635,034,000	575,130,000	-296,033,000	-774,041,000	918,124,000	349,864,000	1,669,093,000	497,661,000	-393,596,000
cash, cash equivalents, and restricted cash, beginning of period	0	3,435,925,000		0	0	2,230,349,000		0	0	1,177,382,000		0	0	4,101,539,000		0	0	3,961,449,000		0	0	526,707,000		0	0	721,692,000
cash, cash equivalents, and restricted cash, end of period	-888,735,000	3,878,739,000		455,247,000	-328,444,000	2,706,361,000		-681,029,000	1,013,655,000	2,819,476,000		171,611,000	-1,687,868,000	3,319,781,000		575,130,000	-296,033,000	3,187,408,000		349,864,000	1,669,093,000	1,024,368,000		292,716,000	142,090,000	485,497,000
deferred tax expense		16,690,000	-9,964,000	-7,822,000	-11,774,000	10,209,000	60,477,000	9,395,000	-18,194,000	20,690,000	18,477,000	-1,544,000	-12,873,000	15,680,000	-14,549,000	-2,110,000	-3,110,000	7,537,000	-27,027,000	-7,250,000	-12,239,000	-11,799,000	9,341,000	-1,552,000	-1,795,000	8,702,000	-5,574,000	4,879,000	828,808	921,718	-16,406					-580,496	463,559				-19,668,337			9,523	991,630																						-331,494	-106,894	-381,460	-113,294	-320,638
gains on mortgage loans sold
investment losses (gains) on sales							-14,000												0	-651,000	128,000	-463,000		-417,000	4,466,000	1,960,000
losses (gains) on disposition of other real estate and other investments
gain on remeasurement of previously held noncontrolling interest											0	0	0	-5,500,000
gains on commercial loans sold
decrease (increase) in other assets						-34,471,000					-26,670,000				51,434,000	-1,923,000	-46,158,000	70,174,000
purchase of loans
purchases of premises and equipment and software																																												-1,933,608	-1,523,685	-2,147,442	-4,003,674	-8,772,531	-6,525,662	-2,213,640	-1,679,977	-3,251,339	-1,867,150	-1,727,485	-2,603,806	-974,721	-1,671,910	-1,132,227	-2,292,955	-941,081	-855,709	-2,619,540	-233,346	-104,806	-903,859	-1,383,847	-1,046,404			-885,838	-219,717
purchase of bank owned life insurance																																-8,352,344	0	0	-30,000,000
proceeds from bank owned life insurance settlement
proceeds from sales of software, premises, and equipment
acquisitions, net of cash acquired																							0
proceeds from sale (purchase) of federal home loan bank stock
purchase of other intangible assets
repayment of other borrowings
issuance of common stock pursuant to performance-based vesting (psus) and time-based vesting (rsus) restricted stock units, net of shares withheld for taxes and related tax benefit
exercise of common stock options, net of shares surrendered for taxes			8,588,000	-9,846,000	-447,000	-4,137,000	-421,000	-373,000	-305,000	-2,116,000	-289,000	-346,000	-438,000	-3,641,000	-88,000	-251,000	-639,000	-2,152,000
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
net decrease in securities purchased under agreements to resell				5,423,000	482,119,000	3,987,000
issuance of common stock pursuant to rsa, rsu and psu agreements, net of shares withheld for taxes				9,266,000	0	-14,427,000
purchase of fhlb stock					11,382,000	-11,420,000		11,877,000	-11,534,000	-37,065,000
net decrease in securities sold under agreements to repurchase						-8,071,000																				-4,043,000			10,515,386	-16,282,804											4,440,087																		-24,064,130
proceeds from (payments for) derivative instruments																			0	0
issuance of common stock pursuant to restricted share award agreements, restricted stock unit agreements and performance stock unit agreements, net of shares withheld for taxes
losses (gains) on dispositions of other real estate and other investments								0	35,000	47,000						-180,000	-674,000	-132,000				2,309,000		174,000				-244,000
acquisition, net of cash acquired												0	0	-30,415,000
repayments of other borrowings												0	0	-29,547,000
decrease in other liabilities													264,000	-98,465,000																-2,169,127	-6,576,105			-4,268,695	-8,339,670																			-3,982,105	-257,260		100,550	-1,057,661	-2,504,034				-11,336,411				-234,719		-172,025	609,246	-1,979,888
issuance of common stock pursuant to rsu and psu agreements, net of shares withheld for taxes									0	-3,645,000		-1,000	0	-5,461,000
decrease in other assets										44,525,000			-23,030,000	33,554,000																	527,594	-1,308,027	2,299,363	7,525,913	3,050,703	10,612,699	6,935,497					11,317,664	8,577,073		11,164,060				8,416,036				-33,537
investment gains on sales											0					0												-11,000
proceeds from subordinated debt and other borrowings, net of issuance costs
issuance of preferred stock, net of issuance costs																			0	-506,000
issuance of common stock pursuant to restricted and performance stock unit agreements, net of shares withheld for taxes
repurchase of common stock																			0	0	0	-50,790,000	-12,927,000	-11,065,000	-7,375,000	-30,049,000
gains on dispositions of other real estate and other investments												-159,000	0	-20,000												-50,000				-32,400
proceeds from derivative instruments																0
net decrease in cash, cash equivalents, and restricted cash												171,611,000	-1,687,868,000	-781,758,000											142,090,000	-236,195,000
increase in securities purchased under agreements to resell													3,877,000	-332,753,000	-500,000,000	0	-50,000,000	-450,000,000
proceeds from sale of fhlb stock																2,273,000	2,446,000	7,883,000
proceeds from sale of federal home loan bank stock
purchase of trade name																			0	0
issuance of common stock pursuant to restricted stock unit agreement, net of shares withheld for taxes															0	-26,000	-3,000	-3,761,000	0	0	-20,000	-2,468,000
advances of other borrowings, net of issuance costs
losses on disposition of other real estate and other investments
gains on other loans sold
purchase of boli
proceeds from boli settlement
net increase in repurchase agreements
advances from federal home loan bank: issuances																						650,000,000	100,000,000
advances from federal home loan bank: payments
federal home loan bank: advances, net of restructuring charges
exercise of common stock options, net of repurchase of restricted shares																				-300,000	-327,000	-1,953,000		-397,000	-792,000	-3,357,000
commercial loans held for sale:
loans originated																					-101,567,000	-78,671,000		-105,707,000	-129,630,000	-80,117,000		-65,156,000	117,034,687	-147,888,687	-61,458,365	-64,969,414	-93,489,781	-118,868,434	-107,845,659	-132,659,332	-131,898,290	-116,678,489	-105,694,598	-393,771,734,147	-113,103,590	-73,093,729	-62,944,534	-137,103,858	-135,478,975	-101,443,588	-70,806,622	-116,795,399	-100,517,301	-218,037,080	-191,052,542	-81,627,360	-69,096,570	-81,655,974	-61,526,765	-44,789,755	-43,248,180	-45,030,922	-36,739,515	-27,516,021	-42,558,978	-40,862,000	-21,034,095	-28,391,360	-25,884,074	-27,238,533	-21,360,167	-16,000,930	-26,114,220	-16,061,046	-10,844,562
loans sold																					92,841,000	90,003,000		106,722,000	123,989,000	82,225,000		75,477,000	-141,869,223	163,949,000	61,290,000	70,194,000	105,817,000	123,181,000	120,569,000	132,609,601	130,801,000	105,365,000	119,023,000	378,752,271,526	104,716,000	68,505,889	70,980,585	143,792,783	137,093,904	92,144,366	72,195,961	120,759,507	114,049,274	216,357,625	192,931,675	72,096,686	71,903,330	79,692,549	59,757,305	43,461,852	42,895,367	52,198,238	31,044,228	32,271,223	41,655,692	39,815,818	20,558,889	29,091,311	26,489,583	23,896,650	20,157,167	19,368,150	24,965,918	16,264,550	8,369,840
consumer loans held for sale:
federal home loan bank: issuances, net of restructuring charges
federal home loan bank: payments/maturities
increase in other borrowings, net of issuance costs																					56,633,000	-65,000
decrease in other borrowings																					-9,579,000	-80,000,000		-163,023,000	-20,632,000	-520,000		-20,000			-625,000				-625,000
proceeds related to derivative instruments																						35,680,000
advances from federal home loan bank: payments/maturities																						-395,014,000
benefit from loan losses																							4,644,000	8,260,000	7,195,000	7,184,000	9,319,000	8,725,000	5,280,101	3,893,570	487,638	2,225,114	684,956	2,774,048	2,172,404	2,487,938	1,412,575	634,072	1,034,245	21,781,254,233	3,632,440	6,587,189	6,139,138	5,171,527	4,789,322	30,508,685	13,225,920	15,694,281	22,134,025	65,320,390	13,609,535	3,710,131	3,124,819	2,787,470	1,591,123	2,259,813	772,064	899,998	787,966	1,051,394	586,589	1,706,865	387,184	701,722	366,304	482,690	601,250	1,134,101	1,012,000	448,474	353,848
revaluation of deferred tax assets and liabilities
payments related to derivative instruments																							-68,850,000	0
principal payments of capital lease obligation																											-50,000	-40,000
proceeds from common stock issuance
exercise of common stock options and stock appreciation rights, net of shares surrendered for taxes
cash, cash equivalents, and restricted cash, beginning of year
cash, cash equivalents, and restricted cash, end of year
depreciation, amortization and accretion expense
advances from federal home loan bank:
issuances																									1,075,000,000	1,147,500,000		127,906,000	897,000,000	631,000,000	175,000,000	-24,000,000	299,961,718	84,038,282	240,000,000	25,000,000	210,000,000	70,000,000	215,000,000	214,950,000,000				0	20,000,000	0	70,000,000	0	10,000,000	25,000,000	35,000,000	10,053,696	25,252,122	15,225,925	70,000,000	45,000,000	-10,000,000			25,000,000	0	0	31,000,000	35,000,000	0	15,000,000	12,000,000	12,000,000	22,000,000	10,000,000	4,000,000
payments/maturities																									-1,236,014,000	-470,014,000		-189,170,000	-730,049,555	-315,015,246	-115,016,116		-510,036,470	40,944,910	-115,036,641		-290,088,331	-25,017,932	-215,017,901
proceeds from sale of mortgage servicing rights
increase in equity method investment
common dividends paid
exercise of common stock options and stock appreciation rights, net of repurchase of restricted shares																												-628,000
net increase in cash and cash equivalents																												-95,843,000				-2,202,722	-30,029,585							-16,415,090,202	-35,716,263	75,480,971	-47,815,506	-61,987,883	11,869,574	143,424,268	-71,321,852	45,578,822	11,377,683							41,295,872	-24,793,264	18,339,569	-4,857,164	-20,480,702	132,855	33,274,992	20,937,435	-38,417,081	37,915,887	14,226,609	18,183,068	-11,370,739	-8,391,274	7,502,230	-8,178,480
cash and cash equivalents, beginning of period																												0	0	320,951,333	208,938,737		0	0	165,288,669		0	0	172,163,040		0	0	188,586,181		0	0	166,602,074		0	0	90,252,755		0	0	122,503,863		0	0	92,518,850	0	0	0	58,654,270	0	0	0	26,745,787	0	0	0	47,184,050
cash and cash equivalents, end of period																												-95,843,000	89,203,419	382,577,673	170,937,407		-30,029,585	141,611,778	99,559,266		-62,678,937	78,750,496	132,067,328		-35,716,263	75,480,971	140,770,675		11,869,574	143,424,268	95,280,222		11,377,683	-43,646,611	153,292,180		-53,811,516	28,923,531	116,286,590		-24,793,264	18,339,569	87,661,686	-20,480,702	132,855	33,274,992	79,591,705	-38,417,081	37,915,887	14,226,609	44,928,855	-11,370,739	-8,391,274	7,502,230	39,005,570
gain on other loans sold
other loans held for sale:
depreciation, amortization, and accretion																													1,649,132	-428,254
gain on sale of investment securities																																	1,441,234				49,784				-376,509	-610,302	159,103																						0	0	-114,410			0	-248,353
mortgage loans held for sale:
increase in other borrowings																													20,631,756	67,344,645			-625,000				-15,692,708
exercise of common stock options and stock appreciation rights,
net of repurchase of restricted shares																													715,693	3,058,559	1,247,220
net decrease in cash and cash equivalents																													89,203,419	61,626,340	-38,001,330				-65,729,403				-40,095,712												63,039,425				-6,217,273
gains from equity method investment																														-5,147,524
changes in other loans held for sale																														-10,504,481
increase in equity-method investment																														-74,100,000
dividends received from equity-method investment																														4,920,103
depreciation and amortization																															2,258,990	2,327,687	2,295,247	2,190,407	2,432,535	2,658,981	2,625,629	2,262,681	2,660,347	10,942,212,600	2,570,449	2,855,067	2,795,884	2,742,272	2,789,940	3,091,983	2,875,880	2,970,868	2,600,163	2,582,918	2,650,715	2,497,231									1,542,808	1,446,864	655,793	277,361	632,175	450,078	339,766	388,405	314,740	284,375	259,935
decrease in other investments																															-2,216
net decrease in deposits																															-32,895,938				-112,293,132				-66,220,256
investment gains on sales and impairments
net decrease in repurchase agreements
payments																																										-137,260	-10,019,502	-19,459	-30,019,418	-25,815,195	-125,295,583	-10,292,650	-15,289,746	-286,872	-15,284,031	-15,280,007	-5,275,881	-5,270,231	-3,336,883	-49,263,685	18,986,391	-45,013,610	-27,013,609	-13,610	-5,009,073	-33,518,145	-23,000,000	-18,000,000	-25,000,000	-17,000,000	-14,000,000	-10,000,000	-18,000,000	-3,000,000	-8,000,000
net increase in subordinated debt and other borrowings
repurchase of common stock warrants
exercise of common stock options and stock appreciation rights																																1,604,216	705,800	362,692	222,200	127,413	105,783	228,049	405,438	864,130,759	222,502	-17,591	469,330	864,005	1,192,800	387,850	592,409	27,249	28,127	11,257	599,401				739,855
repurchase of preferred shares outstanding																																				0	0
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
preferred dividends paid																																				1	0	-1,236,981	-890,624	-4,888,276,502	-1,187,498	-1,187,500	-1,187,500	-1,187,500	-1,187,500	-1,187,500	-1,187,500	-1,187,501	-1,187,499	-1,187,500	-831,250
repurchase of outstanding warrants
(gains) losses on dispositions of other real estate and other investments																																			-866,306
gains on sales of investment securities
decrease (increase) in other investments																																				-759,943
net increase in other borrowings
(repurchase) exercise of common stock warrants
gain on sale of premises
other investments																																						-862,496	-286,569	-407,110,696	-137,955	-17,248	-238,101	0	-925,000	-22,076	-931,600	-2,150,000	-1,009,030	-2,096,159	-1,603,900
gain on mortgage loan sales																																							-1,494,472
(gain) loss on sale of investment securities																																							-113,600
gain on loan sales																																								-4,152,443,087	-1,295,278	-789,258	-609,377					-1,107,875	-899,553	-1,633,342	-1,287,772
deferred tax (benefit) expense																																																494,278	-2,600,472	-18,790,013	-3,749,584	-1,345,586			1,487,344	2,390,185
losses on other real estate and other investments																																								14,070,614,798	5,134,333
activities in available-for-sale securities:
activities in held-to-maturity securities:
net decrease in federal funds purchased																																																	0	-397,000	-71,246,000
federal home loan bank:
net increase in borrowings under lines of credit																																																0	0			0	0
exercise of common stock warrants																																																												0
proceeds from the sale of common stock, net of expenses
decrease (increase) in loans																																									-47,781,117	-10,843,891	-21,304,654		43,953,929	80,638,132	62,168,779
purchases of premises and equipment																																										-354,294	-975,525
losses on foreclosed real estate and other investments																																											3,297,185	6,125,305	7,662,512	6,852,754	4,819,280	7,469,873	791,042	3,336,090	390,390
net gains on sale of premises and equipment
proceeds from the sale of premises and equipment																																																				0
cash and cash equivalents used for acquisitions
net increase in federal funds purchased																																																				71,643,000	0	-194,000	-39,668,000	28,876,000	-14,000	93,000	19,907,000
proceeds from issuance of subordinated debt																																																				0
proceeds from issuances of preferred stock and common stock warrants, net of expenses
gain on loan sales and loan participations																																													-1,586,280	-918,703	-562,598
gain on investment sales																																													0	-2,259,124	-364,550		0	-2,116,095	-4,346,146
net gains on sale of premises and equipment and software																																													0	-670	-4,365
proceeds from the sale of premises and equipment and software																																													0	670	4,365		5,996
net decrease in borrowings under lines of credit
issuance of common stock, net of expenses																																																	0
activities in available for sale securities:
activities in held to maturity securities:
cash and cash equivalents provided by acquisitions
costs incurred in connection with registration of common stock issued in merger																																																												0	0	-10,407	-177,202
net gains on sale of premises																																																	-13,895	-990	-7,899	-19,350	0
cash from acquisition
proceeds from the issuance of subordinated debt
other
cash and cash equivalents provided by acquisitions, net of acquisition costs
increases in other investments
proceeds from the sale of common stock and common stock warrants, net of expenses
proceeds from issuances of preferred stock, net of expenses
gains on loans and loan participations sold																																																					-1,460,478	-879,824	-656,088		-378,682	-638,895	-363,306		-490,254	-470,809	-324,546
other non-cash operating activities
investments in unconsolidated subsidiaries and other entities																																																					-490,250				-399,096	-104,628	-718,846
exercise of common stock options																																																					1,226,510				93,320	74,016	427,541	291,998	125,326	699,155	123,292	31,191	18,808	110,652	14,110	0	17,437
net amortization of premium on securities																																																						189,770	182,563		120,283	123,946	132,221
depreciation and net amortization																																																						1,901,677	1,112,113	1,799,887	970,107	-782,814	1,823,194
purchases of securities available-for-sale																																																							-57,529,865
maturities, prepayments and calls of securities available-for-sale																																																							65,224,367
maturities, prepayments and calls of securities held-to-maturity																																																							15,750,000
purchases of other investments																																																							-1,486,800
net amortization of premiums on securities
gain on loans and loan participations sold																																																																				223,646
tax benefit on exercise of stock awards
cash and cash equivalents acquired in merger with cavalry bancorp, inc., net of acquisition costs
cash and cash equivalents acquired in merger with mid-america bancshares, inc., net of acquisition costs
purchases of other assets																																																												-4,835,676	-752,293	-440,714	-78,975	-1,261,150	-30,000	-775,950	-21,900	-151,169	-20,600	-420,150	-289,800
net cash provided (used in) by operating activities
deferred tax benefit from exercise of stock options
net proceeds from sale of common stock
net amortization of securities																																																													184,156	163,287	244,351		309,226	284,796	244,147
excess tax benefit from stock compensation arrangements																																																													-35,336
net increase in loans																																																													-47,228,584	-123,478,357	-36,438,055		-47,232,729	-40,074,588	-44,424,452		-79,685,428	-31,876,643	-26,441,559
cash and cash equivalents acquired in merger with cavalry bancorp, inc.																																																													0	0	37,420,210
net provided by (cash used) in investing activities																																																															2,232,209
gain on loan participations sold
amortization of unearned compensation associated with restricted shares
activities in securities:
purchases of capital securities of unconsolidated subsidiaries
debt issuance costs related to issuance of subordinated debt
dividends paid to preferred shareholders of pnfp properties, inc.																																																																	0
net proceeds from issuance of common stock
gains on loan participations sold
gain on participations sold																																																																			14,991			-116,461	-121,617
purchases of capital securities of unconsolidated subsidiary
purchases of life insurance policies
net amortization of investment securities
gain on sale of securities available-for-sale
mortgage loans held-for-sale:
advances from federal home loan bank
supplemental disclosure:
cash paid for interest																																																																					1,913,580	1,780,447	1,439,283
cash paid for income taxes																																																																					1,540,000	295,000	1,226,817
transfers of securities available-for-sale to held-to-maturity																																																																					0	0	27,655,669
net amortization of available-for-sale securities																																																																						349,429	189,637

We provide you with 20 years of cash flow statements for Pinnacle Financial Partners stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Pinnacle Financial Partners stock. Explore the full financial landscape of Pinnacle Financial Partners stock with our expertly curated income statements.

The information provided in this report about Pinnacle Financial Partners stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.